Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibitory effects of TFPI variants on thrombin and factor Xa generation in fibrinogen-deficient human plasma.

Thrombosis research - 15 Dec 1994

Kaiser B, Jeske W, Hoppensteadt D, Fareed J

Abstract excerpt

Using a fast kinetic centrifugal analyzer, the inhibitory effects of glycosylated and unglycosylated full-length and truncated forms of TFPI on protease generation were studied in fibrinogen-deficient human plasma after extrinsic (EA) or intrinsic (IA) activation of coagulation. When the assay system was supplemented with increasing amounts of the TFPI variants the generation of both thrombin and factor Xa was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Genetic Variation
Share to Lipoproteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Structure-Activity Relationship

Share to Thrombin

Source

Identifiers

PMID: 7900103
DOI: 10.1016/0049-3848(94)90285-2

Genes

TFPI

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibitory effects of TFPI variants on thrombin and factor Xa generation in fibrinogen-deficient human plasma.PMID 7900103Read ↗

Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor.Semantic proximity Read ↗

Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma.Semantic proximity Read ↗

Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme.Semantic proximity Read ↗

In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency.Semantic proximity Read ↗

Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency.Semantic proximity Read ↗

Critical evaluation of kinetic schemes for coagulationSemantic proximity Read ↗

In vitro evaluation of factor IX as novel treatment for factor XI deficiencySemantic proximity Read ↗

Development of a Plasma-Based Assay to Measure the Susceptibility of Factor V to Inhibition by the C-Terminus of TFPIα.Semantic proximity Read ↗

Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis.Semantic proximity Read ↗

The M358R variant of α(1)-proteinase inhibitor inhibits coagulation factor VIIa.Semantic proximity Read ↗

Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.Semantic proximity Read ↗

Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.